HSBC Holdings
EVH icon

HSBC Holdings’s Evolent Health EVH Stock Holding History

HSBC Holdings’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.28M Buy
237,199
+76,074
+47% +$292K ﹤0.01% 1803
2026
Q1 		$362K Hold
161,125
– – ﹤0.01% 2370
2025
Q4 		$640K Sell
161,125
-49,868
-24% -$277K ﹤0.01% 2181
2025
Q3 		$1.8M Buy
210,993
+199,593
+1,751% +$1.94M ﹤0.01% 1545
2025
Q2 		$128K Sell
11,400
-99,996
-90% -$918K ﹤0.01% 2801
2025
Q1 		$1.05M Buy
111,396
+54,186
+95% +$547K ﹤0.01% 1734
2024
Q4 		$632K Buy
+57,210
New +$1.01M ﹤0.01% 2046
2024
Q3 		– Sell
-12,701
Closed -$248K – 3028
2024
Q2 		$248K Sell
12,701
-138,573
-92% -$3.54M ﹤0.01% 2424
2024
Q1 		$4.96M Buy
151,274
+44,119
+41% +$1.41M ﹤0.01% 1103
2023
Q4 		$3.54M Buy
107,155
+11,372
+12% +$322K ﹤0.01% 1276
2023
Q3 		$2.61M Buy
95,783
+7,626
+9% +$212K ﹤0.01% 1337
2023
Q2 		$2.67M Buy
+88,157
New +$2.85M ﹤0.01% 1315
2023
Q1 		– Sell
-14,494
Closed -$405K – 2783
2022
Q4 		$405K Sell
14,494
-5,290
-27% -$152K ﹤0.01% 2376
2022
Q3 		$724K Buy
19,784
+8,616
+77% +$304K ﹤0.01% 1990
2022
Q2 		$343K Sell
11,168
-7,417
-40% -$216K ﹤0.01% 2555
2022
Q1 		$600K Buy
18,585
+231
+1% +$6.05K ﹤0.01% 2282
2021
Q4 		$504K Buy
+18,354
New +$527K ﹤0.01% 2460
2020
Q3 		– Sell
-15,634
Closed -$111K – 2762
2020
Q2 		$111K Buy
+15,634
New +$105K ﹤0.01% 2504
2020
Q1 		– Sell
-31,155
Closed -$286K – 2788
2019
Q4 		$286K Sell
31,155
-44,248
-59% -$359K ﹤0.01% 2584
2019
Q3 		$542K Buy
+75,403
New +$541K ﹤0.01% 2292

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

HSBC Holdings's EVH Position: Q2 2026 in Review

HSBC Holdings increased its Evolent Health (EVH) stake by 47% in Q2 2026, buying an estimated $292K and bringing the position to 237,199 shares worth $1.28M. The position accounts for ﹤0.01% of the portfolio, ranked #1803.

HSBC Holdings first reported a position in EVH in Q3 2019 and has held it in 20 quarters since. The position peaked at $4.96M in Q1 2024. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • HSBC Holdings held 237,199 shares of Evolent Health worth $1.28M as of Q2 2026.
  • HSBC Holdings bought 76,074 Evolent Health shares in Q2 2026, an estimated $292K.
  • Evolent Health made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #1803 holding.
  • HSBC Holdings first reported a position in Evolent Health in Q3 2019 and has held it in 20 quarters since.
  • HSBC Holdings's Evolent Health position peaked at $4.96M in Q1 2024.
  • 198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.